Upadacitinib – July 2022

• Brand names:
  • Rinvoq®
• Pharmaceutical Company:
  • AbbVie Pty Ltd
• Condition/Indication: Ulcerative colitis
• Meeting Date: July 2022
• Public Summary Document (PSD) July 2022 November 2022 PBAC Meetings - (PDF 967KB)
• Public Summary Document (PSD) July 2022 November 2022 PBAC Meetings - (Word 384KB)

Related Public Summary Documents

• Upadacitinib – November 2022